Residue depletion of tilmicosin in cattle after subcutaneous administration

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 14, 2006, Pages 5208-5213

  Jiang, Haiyang ^a,b   Ding, Shuangyang ^a,b   Li, Jiancheng ^a,b   An, Dianjin ^a   Li, Cun ^a   Shen, Jianzhong ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b National Reference Laboratories for Veterinary Drug Residue   (China)

Author keywords

Cattle; Depletion; Residue; Tilmicosin; Withdrawal time

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; DRUG RESIDUE; MACROLIDE; TILMICOSIN; TYLOSIN;

ADIPOSE TISSUE; ANIMAL; ARTICLE; CATTLE; CHEMISTRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; MALE; METABOLISM; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADIPOSE TISSUE; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; FEMALE; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIVER; MACROLIDES; MALE; MUSCLE, SKELETAL; SENSITIVITY AND SPECIFICITY; TYLOSIN;

ANIMALIA; BOS TAURUS;

EID: 33746552259     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf060863x     Document Type: Article

References (33)

1. Ziv, G.; Shem-Tov, M.; Glickman, A.; Winkler, M.; Saran, A. Tilmicosin antibacterial activity and pharmacokinetics in cows. J. Vet. Pharmacol. Ther. 1995, 18, 340-345.
2. Ose, E. E. In vitro antibacterial properties EL-870, a new semi-synthetic macrolide antibiotic. J. Antibiot. 1987, 40, 190-194.
3. Fodor, L.; Varga, J.; Gallowitsch, F.; Horvath-Papp, I.; Miklos, G.; Lajcsak, A.; Harmath, A. Treatment of calf pneumonia with tilmicosin. Acta Vet. Hung. 1993, 41, 41-49.
4. Thompson, T. D.; Laudert, S. B.; Chamberland, S.; Lawrence, K. Micotil-Pharmacokinetics of tilmicosin, a semi-synthetic macrolide antibiotic, in acutely pneumonic cattle and primary alveolar macrophages. In European Association for Veterinary Pharmacology and Therapeutics. Proceedings of the 6th International Congress; Blackwell Scientific Publications: Edinburgh, Oxford, United Kingdom, 1994; pp 31-32.
5. Musser, J.; Mechor, G. D.; Grohn, Y. T.; Dubovi, E. J.; Shin, S. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves. J. Am. Vet. Med. Assoc. 1996, 208, 102-106.
6. Modric, S.; Webb, A. I.; Derendorf, H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J. Vet. Pharmacol. Ther. 1998, 21, 444-452.
7. Huwyler, U.; Reeve, J. L.; Korfitsen, J.; Liesegang, A.; Wanner, M. Efficacy evaluation of the use of oral tilmicosin in pneumonic calves. Schweiz. Archiv Tierheilkunde 1999, 141, 203-208.
8. Mckellar, Q. A. Pharmacology and therapeutics. In Diseases of Sheep, 3rd ed.; Martin, W. B., Aitken, I. D., Eds.; Blackwell Scientific Publications: Oxford, United Kingdom, 2000; pp 463-473.
9. Morck, D. W.; Merrill, J. K.; Gard, M. S.; Olson, M. E.; Nation, P. N. Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin. Can. J. Vet. Res. 1997, 61, 187-192.
10. Botsch, R.; Wittkowski, G. Prophylaxis and treatment of enzootic bronchopneumonia. Tierarztliche Umsch. 2000, 55, 535-539.
11. Frank, G. H.; Briggs, R. E.; Loan, R. W.; Purdy, C. W.; Zehr, E. S. Effects of tilmicosin treatment on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract disease. Am. J. Vet. Res. 2000, 61, 525-529.
12. Naccari, F.; Giofre, F.; Pellegrino, M.; Calo, M.; Licata, P.; Carli, S. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep. Vet. Rec. 2001, 148, 773-776.
13. Naccari, F.; Martino, D.; Giofre, F.; Passantino, A.; Montis, P. Therapeutic efficacy of tilmicosin in ovine mammary infections. Small Ruminant Res. 2003, 47, 1-9.
14. Moore, G. M.; Mowrey, D. H.; Tonkinson, L. V.; Lechtenberg, K. F.; Schneider, J. H. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine. Am. J. Vet. Res. 1996, 57, 220-223.
15. Moore, G.; Basson, R. P.; Tonkinson, L. V. Clinical field trials with tilmicosin in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Am. J. Vet. Res. 1996, 57, 224-228.
16. Wallgren, P.; Segall, T. A.; Pedersen, M.; Gunnarson, A. Experimental infections with Actinobacillus pleuropneumoniae in pigs. II. Comparison of antibiotics for oral strategic treatment. J. Vet. Med. B 1999, 46, 261-269.
17. Wayne, C.; Geoff, C. G.; Craig, D. C. S. Determination of tylosin and tilmicosin residues in animal tissues by reversed-phase liquid chromatography J. AOAC Int. 1994, 77, 331-333.
18. Juhel, G. M.; Anger, B.; Laurentie, M. Multiresidue chromatographic method for the determination of macrolide residues in muscle by high-performance liquid chromatography with UV detection. J. AOAC Int. 1999, 82, 1046-1053.
19. Carolyn, M. S.; Jen, P. C.; David, T. E.; John, W. M.; James, M. T.; Robin, S. A. Determination of tilmicosin residues in chickens, cattle, swine, and sheep tissues by liquid chromatography. J. AOAC Int. 2000, 83, 837-846.
20. Leal, C.; Codony, R.; Compano, R.; Granados, M.; Prat, M. D. Determination of macrolide antibiotics by liquid chromatography. J. Chromatogr. A 2001, 910, 285-290.
21. Beechinor, J. G.; Bloomfield, F. J. Variability in residue concentrations of tilmicosin in cattle muscle. Vet. Rec. 2001, 149, 182-183.
22. Clark, S. B.; O'Rangers, J. J.; Rowe, W. D.; Madson, M. R.; Hurlbut, J. A.; Sofos, J. N.; Fuerst, B.; James, G.; Griffith, S.; Readnour, R. S. Interlaboratory comparison of methods for the determination of incurred tilmicosin residues in bovine liver. J. AOAC Int. 2002, 85, 1260-1267.
23. Nagata, T.; Ashizawa, E.; Hashimoto, H. Simultaneous determination of residual fourteen kinds of beta-lactam and macrolide antibiotics in bovine muscles by high-performance liquid chromatography with a diode array detector. J. Food Hyg. Soc. Jpn. 2004, 45, 161-164.
24. Agricultural Department of P.R. China. 235th Bulletin;Agricultural Department of P.R. China: China, 2002.
25. The European Agency for the Evaluation of Medicinal Products. Veterinary medicines evaluation unit: Tilmicosin, summary report [DB/OL], 1996.
26. CFR (Code of Federal Regulations) 556.735, Dec 5, 2002, Washington, DC.
27. Freedom of Information Summary, NADA 140-929.
28. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Note for guidance: approach towards harmonization of withdrawal periods. EMEA/CVMP/036/95, 1995.
29. Beechinor, J. G.; Bloomfield, F. J. Variability in residue concentrations of tilmicosin in cattle muscle. Vet. Rec. 2001, 149, 182-183.
30. Donoho, A. L.; Thomson, T. D.; Giera, D. D.; Hutson, D. H. Tilmicosin in Cattle. Metabolism and Tissue Residues. Xenobiotics and Food Producing Animals. Metabolism and Residues; American Chemical Society Symposium 503; American Chemical Society: Washington, DC, 1992; pp 158-167.
31. Helton, G. S. L.; Thompson, T. D.; Readnour, R. S. A study of tilmicosin residues in milk following subcutaneous administration to lactating dairy cows. Can. Vet. J. 1993, 34 (10), 619-621.
32. Donkersgoed, J.; VanderKop, M.; Salisbury, C.; Sears, L.; Holowath, J.; van-Donkersgoed, J. The effect of administering long-acting oxytetracycline and tilmicosin either by dart gun or by hand on injection site lesions and drug residues in beef cattle. Can. Vet. J. 1999, 40 (8), 583-587.
33. Zhang, Y.; Jiang, J.; Jin, X.; Shen, Z.; Shen, J.; Fu, C.; Guo, J. Residue depletion of tilmicosin in chicken tissues. J. Agric. Food Chem. 2004, 52, 2602-2605.